RecruitingNCT07017621

Qualitative Study on the Experiences of Mothers 6 to 12 Months After Their Participation in the Mother-baby Groups of the HUGS Study

Sponsor

University Hospital, Toulouse

Enrollment

16 participants

Start Date

Feb 4, 2025

Study Type

OBSERVATIONAL

Conditions

Postpartum Depression (PPD)Postnatal Depression

Summary

The HUGS-QUALI study is a qualitative investigation that explores the experiences of mothers who participated in HUGS mother-baby therapy groups. Conducted 6 to 12 months after the intervention, the study aims to understand how this culturally adapted therapy influences the bond between mothers and their infants and affects their daily lives. By collecting detailed personal stories through in-depth interviews, the study seeks to understand if the adapted HUGS program effectively support French mothers in improving their interactions with their babies, when facing postpartum depression.

Eligibility

Plain Language Summary

Simplified for easier understanding

This qualitative follow-up study is speaking with mothers 6 to 12 months after they participated in mother-baby group therapy sessions (called HUGS groups), to understand their long-term experiences and whether the program had lasting effects on their wellbeing and their relationship with their baby. **You may be eligible if...** - You previously participated in the HUGS mother-baby group sessions as part of the original HUGS study - You have completed your follow-up as part of that original study - The study was conducted at Toulouse University Hospital (Paule de Viguier Maternity), Joseph Ducuing Maternity, or Bordeaux Maternity **You may NOT be eligible if...** - You did not participate in the HUGS group sessions - You decline to participate in this follow-up interview Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.